Steroid Eye Drops in Chronic Central Serous Chorioretinopathy
Status:
Not yet recruiting
Trial end date:
2024-02-09
Target enrollment:
Participant gender:
Summary
In this pilot study the effect and safety of the use of steroid eye drops in chronic central
serous chorioretinopathy (cCSC) will be evaluated. The study is conducted as a randomized
single-blind placebo-controlled trial. Forty patients will be randomized to either steroid
eye drops or placebo eye drops. Patients will self-administer the eye drops three times a day
for four weeks.